Medications

Drug approved to treat tenosynovial giant cell tumor

(HealthDay)—Turalio (pexidartinib) capsules have been approved to treat adults with symptomatic tenosynovial giant cell tumor (TGCT), the U.S. Food and Drug Administration announced.

Genetics

Computer-aided facial analysis helps diagnosis

In rare diseases, the computer-aided image analysis of patient portraits can facilitate and significantly improve diagnosis. This is demonstrated by an international team of scientists under the leadership of the University ...

Diseases, Conditions, Syndromes

ACG: fecal transplant safe in primary sclerosing cholangitis

(HealthDay)—Fecal microbiota transplantation (FMT) from a rationally selected donor seems safe and effective for patients with primary sclerosing cholangitis (PSC), according to a study presented at the World Congress of ...

Medical research

Biomarker monitors testosterone therapy for osteoporosis

That biomarker, an enzyme called alkaline phosphatase, can be checked through a test similar to a routine blood draw, making this type of screening preferable to the more expensive and invasive DEXA scan, which measures bone ...

Diseases, Conditions, Syndromes

Alkaline phosphatase, bilirubin predict outcomes in PBC

(HealthDay)—For patients with primary biliary cirrhosis (PBC), levels of alkaline phosphatase and bilirubin predict clinical outcome, according to a meta-analysis published in the December issue of Gastroenterology.

Oncology & Cancer

Cabozantinib active in castration-resistant prostate cancer

(HealthDay)—The orally bioavailable tyrosine kinase inhibitor cabozantinib (XL184) has clinical activity in men with castration-resistant prostate cancer (CRPC), according to a study published online Nov. 19 in the Journal ...

page 2 from 3